Real-world clinical outcomes and treatment patterns among patients with triple-class exposed multiple myeloma: an analysis using the Connect® multiple myeloma disease registry

被引：0
|
作者：
Lee, Hans [1 ]
Ailawadhi, Sikander [2 ]
Dhanda, Devender [3 ]
Patwardhan, Pallavi [3 ]
Yu, Edward [3 ]
Liu, Liang [3 ]
Rifkin, Robert [4 ]
Terebelo, Howard [5 ]
Abonour, Rafat [6 ]
Narang, Mohit [7 ]
Gasparetto, Cristina [8 ]
Toomey, Kathleen [9 ]
Hardin, James [10 ]
Durie, Brian [11 ]
Jagannath, Sundar [12 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr Houston, Dept Lymphoma Myeloma, Houston, TX USA
[2] Mayo Clin, Jacksonville, FL USA
[3] Bristol Myers Squibb, Princeton, NJ USA
[4] US Oncol Res, Rocky Mt Canc Ctr, Denver, CO USA
[5] Ascens Providence Hosp, Southfield, MI USA
[6] Indiana Univ Sch Med, Indianapolis, IN USA
[7] Maryland Oncol Hematol, Columbia, MD USA
[8] Duke Univ, Sch Med, Durham, NC USA
[9] Steeplechase Canc Ctr, Somerville, NJ USA
[10] Univ South Carolina, Arnold Sch Publ Hlth, Columbia, SC USA
[11] Cedars Sinai Samuel Oschin Canc Ctr, Los Angeles, CA USA
[12] Mt Sinai Med Ctr, New York, NY USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-285
引用
收藏
页码：S193 / S194
页数：2
相关论文
共 50 条
  • [21] TRIATLON - Triple Class Exposed/Refractory Multiple Myeloma Patients: A Real World Analysis (RWA) from the Austrian Myeloma Registry (AMR)
    Willenbacher, Ella
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 : S37 - S37
  • [22] CHARACTERISTICS AND TREATMENT PATTERNS OF MEDICARE BENEFICIARIES WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Hlavacek, P.
    Silverstein, A.
    Petrilla, A.
    Leinwand, B., I
    Johnson, W.
    Schroeder, A.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S486 - S487
  • [23] Teclistamab versus real-world physician's choice of therapy in triple-class exposed relapsed/refractory multiple myeloma
    Krishnan, Amrita
    Nooka, Ajay K.
    Chari, Ajai
    Garfall, Alfred L.
    Martin, Thomas G.
    Nair, Sandhya
    Lin, Xiwu
    Qi, Keqin
    Londhe, Anil
    Pei, Lixia
    Ammann, Eric
    Kobos, Rachel
    Smit, Jennifer
    Parekh, Trilok
    Marshall, Alexander
    Slavcev, Mary
    Usmani, Saad Z.
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2023, 12 (06)
  • [24] Treatment Patterns and Outcomes in Triple-Class Exposed Patients With Relapsed and Refractory Multiple Myeloma: Findings From the Multinational ITEMISE Study
    Dhanasiri, Sujith
    Hollier-Hann, Georgia
    Stothard, Catherine
    Dhanda, Devender S.
    Davies, Faith E.
    Rodriguez-Otero, Paula
    [J]. CLINICAL THERAPEUTICS, 2021, 43 (11) : 1983 - +
  • [25] Real-World Effectiveness and Safety of Belantamab Mafodotin Monotherapy in Triple-Class Refractory Multiple Myeloma
    Ntanasis-Stathopoulos, Ioannis
    Malandrakis, Panagiotis
    Fotiou, Despina
    Migkou, Magdalini
    Theodorakakou, Foteini
    Roussou, Maria
    Eleutherakis-Papaiakovou, Evangelos
    Spiliopoulou, Vassiliki
    Kastritis, Efstathios
    Terpos, Evangelos
    Dimopoulos, Meletios-Athanasios
    Gavriatopoulou, Maria
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (14)
  • [26] Treatment Patterns, Survival, Quality of Life, and Healthcare Resource Use Among Patients With Triple-Class Refractory Multiple Myeloma in US Clinical Practice: Findings From the Connect MM Disease Registry
    Lee, Hans C.
    Ramasamy, Karthik
    Weisel, Katja
    Abonour, Rafat
    Hardin, James W.
    Rifkin, Robert M.
    Ailawadhi, Sikander
    Terebelo, Howard R.
    Durie, Brian G. M.
    Tang, Derek
    Joshi, Prashant
    Liu, Liang
    Jou, Ying-Ming
    Che, Min
    Hernandez, Gabriela
    Narang, Mohit
    Toomey, Kathleen
    Gasparetto, Cristina
    Wagner, Lynne I.
    Jagannath, Sundar
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (02): : 112 - 122
  • [27] Real-World Evaluation of Outcomes in Relapsed/Refractory Multiple Myeloma Patients That Are Triple-Class Exposed after Receiving 2 or More Prior Lines of Therapy
    Radwanski, Katherine
    Yu, Junhua
    Pierce, Kody
    Talati, Chetasi
    Stricker, Steve
    Jiao, Shiyin
    Bueno, Orlando
    [J]. BLOOD, 2023, 142
  • [28] Real-World Study of Patients with Triple-Class Exposed Relapsed/Refractory Multiple Myeloma: Analysis across a Spectrum of Advanced Disease Stage Medicare Patients in the United States
    Delea, Thomas
    Moynahan, Aaron
    Ge, Wenzhen
    Song, Xue
    Kroog, Glenn S.
    Noguera-Troise, Irene
    Lorenc, Karen Rodriguez
    Ma, Qiufei
    [J]. BLOOD, 2023, 142
  • [29] Patient Characteristics, Treatment Patterns, and Outcomes in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma Patients, a Retrospective Observational Study Using Czech
    Maisnar, Vladimir
    Pour, Ludek
    Spicka, Ivan
    Jelinek, Tomas
    Minarik, Jiri
    Jungova, Alexandra
    Stork, Martin
    Straub, Jan
    Radocha, Jakub
    Pika, Tomas
    Pospisilova, Lenka
    Nair, Sandhya
    Kunovszki, Peter
    Hajek, Roman
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (02): : 145 - 153
  • [30] Treatment Options for Triple-class Refractory Multiple Myeloma
    Mikhael, Joseph
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (01): : 1 - 7
12345